Pulseless ventricular tachycardia natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}}{{Aisha}}
{{CMG}}; {{AE}}{{Aisha}}
==Overview==
==Overview==
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*On initial presentation, patients with impending [[pulseless ventricular tachycardia]] may present with signs of inadequate [[cardiac perfusion]] such as [[chest pain]], [[shortness of breath]], [[diaphoresis]], [[palpitations]], and [[syncope]]. Physical examination may be positive for [[hypotension]], [[tachycardia]], [[tachypnea]], [[increased JVD]], and an [[S1]]. Eventually, Pulseless ventricular tachycardia ensues and patients become unconscious and unresponsive with no detectable pulse. If [[defibrillation]] is not begun as soon as possible patients may progress to cardiac arrest and death. <ref name="pmid32119354">{{cite journal |vauthors=Foglesong A, Mathew D |title= |journal= |volume= |issue= |pages= |date= |pmid=32119354 |doi= |url=}}</ref>


OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==


===Natural History===
===Natural History===
*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
*On initial presentation, patients with impending [[pulseless ventricular tachycardia]] may present with signs of inadequate [[cardiac perfusion]] such as [[chest pain]], [[shortness of breath]], [[diaphoresis]], [[palpitations]], and [[syncope]].  
*The symptoms of (disease name) typically develop ___ years after exposure to ___.  
*Physical examination may be positive for [[hypotension]], [[tachycardia]], [[tachypnea]], [[increased JVD]], and an [[S1]].
*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*Eventually, Pulseless ventricular tachycardia ensues and patients become unconscious and unresponsive with no detectable pulse.<ref name="pmid32119354">{{cite journal |vauthors=Foglesong A, Mathew D |title= |journal= |volume= |issue= |pages= |date= |pmid=32119354 |doi= |url=}}</ref>


===Complications===
===Complications===
*Common complications of [disease name] include:
*Common complications of pulseless ventricular tachycardia include:
**[Complication 1]
**[[Cardiac arrest]]/[[sudden cardiac death]]
**[Complication 2]
**[[Anoxic brain injury]] and lifelong neurological complications
**[Complication 3]
**[[Post-cardiac arrest syndrome]]
**[[Ischemic-reperfusion injury]]
**[[Cardiomyopathy]]
**Infection related to [[implantable cardioverter-defibrillator]]


===Prognosis===
===Prognosis===
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
*[[Prognosis]] of pulseless ventricular tachycardia is majorly based on two considerations; the presence of prior expressed or unexpressed cardiac issues, and the time from the beginning of the [[dysrhythmia]] to [[defibrillation]] and conversion to [[sinus rhythm]]and adequate [[perfusion]].<ref name="pmid32119354">{{cite journal |vauthors=Foglesong A, Mathew D |title= |journal= |volume= |issue= |pages= |date= |pmid=32119354 |doi= |url=}}</ref>
*Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
*Up to 50% of patients who are defibrillated within seconds of the onset of [[tachycardia]], have high survival rates while patients who experience delays of up to 15 minutes have a survival rate of as low as 5%.<ref name="pmid10699695">{{cite journal |vauthors=Holmberg M, Holmberg S, Herlitz J |title=Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in sweden |journal=Resuscitation |volume=44 |issue=1 |pages=7–17 |date=March 2000 |pmid=10699695 |doi=10.1016/s0300-9572(99)00155-0 |url=}}</ref>
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
*While the most significant factors affecting prognosis are underlying structural and ischemic cardiac issues, the presence of other [[comorbidities]] also play a significant role.<ref name="pmid32119354">{{cite journal |vauthors=Foglesong A, Mathew D |title= |journal= |volume= |issue= |pages= |date= |pmid=32119354 |doi= |url=}}</ref>
*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.


==References==
==References==

Revision as of 11:17, 7 June 2020

Pulseless ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulseless ventricular tachycardia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography

Cardiac MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulseless ventricular tachycardia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulseless ventricular tachycardia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulseless ventricular tachycardia natural history, complications and prognosis

CDC on Pulseless ventricular tachycardia natural history, complications and prognosis

Pulseless ventricular tachycardia natural history, complications and prognosis in the news

Blogs on Pulseless ventricular tachycardia natural history, complications and prognosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pulseless ventricular tachycardia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Overview

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

  • Prognosis of pulseless ventricular tachycardia is majorly based on two considerations; the presence of prior expressed or unexpressed cardiac issues, and the time from the beginning of the dysrhythmia to defibrillation and conversion to sinus rhythmand adequate perfusion.[1]
  • Up to 50% of patients who are defibrillated within seconds of the onset of tachycardia, have high survival rates while patients who experience delays of up to 15 minutes have a survival rate of as low as 5%.[2]
  • While the most significant factors affecting prognosis are underlying structural and ischemic cardiac issues, the presence of other comorbidities also play a significant role.[1]

References

  1. 1.0 1.1 1.2 1.3 Foglesong A, Mathew D. PMID 32119354 Check |pmid= value (help). Missing or empty |title= (help)
  2. Holmberg M, Holmberg S, Herlitz J (March 2000). "Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in sweden". Resuscitation. 44 (1): 7–17. doi:10.1016/s0300-9572(99)00155-0. PMID 10699695.


Template:WH Template:WS